Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data UPEXI, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
7.41
24.1
23.1
36.4
26
15.8
25
Cost of revenue
4.84
12.2
8.2
15.4
13.2
4.94
2.63
Gross profit
2.57
11.9
14.9
21
12.8
10.9
22.4
Selling and marketing
1.37
2.39
5.12
6.07
5.99
4
2.9
General and administrative
6.04
6.44
9.14
6.88
6.77
11.9
26.4
Operating expenses
7.41
10.5
21.4
33.3
35.3
23.4
263
Operating income
-4.84
1.43
-6.49
-12.3
-22.5
-12.5
-241
Interest expense
0.01
0.04
0.1
0.1
0.06
Other non-operating income
0.55
-0.27
0.1
-4.68
-3.14
-1.18
-5.22
Pre-tax income
-5.38
1.7
-6.39
-17
-25.6
-13.7
-246
Income tax
0
1.28
0.52
3.05
-0.33
0
0
Income from continuing operations
-5.87
-13.9
-25.3
-13.7
Net income
-5.38
2.98
-2.05
-17.5
-23.7
-13.7
-246
EBITDA
-4.23
2.46
-3.76
-8.8
-18.8
-11.7
-240
EPS, basic
-34.59
16.31
-8.48
-18.94
-23.03
-1.73
-3.87
EPS, diluted
-34.59
13.70
-8.48
-18.94
-23.03
-1.73
-3.87
Shares, basic (weighted)
0.15
0.18
0.82
0.89
1.03
7.91
63.5
Shares, diluted (weighted)
0.15
0.22
0.82
0.89
1.03
7.91
63.5
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
0.89
14.5
7.15
4.49
0.66
2.98
5.78
Short-term investments
0.09
0
Receivables
0.17
1.28
0.94
1.13
0.61
0.16
0.1
Inventory
1.45
2.09
11.6
4.8
1.43
1.15
0.27
Other current assets
0.15
0.39
0.76
1.11
0.5
0.35
0.99
Total current assets
2.65
18.3
17.1
30
11.4
56.8
117
Property, plant and equipment
1.69
2.83
7.34
2.83
2.36
2.05
0.21
Lease right-of-use assets
0.29
0.42
0.84
0.41
2.42
1.74
0.6
Goodwill
2.41
2.41
4.64
2.89
0.85
0.85
0.67
Intangible assets
1.24
1.85
8.76
6.92
0.24
0.16
0.09
Other non-current assets
0.04
0.05
0.08
0.08
0.28
0.19
0.16
Total assets
6.4
27.3
48.5
63.8
23.5
124
180
Accounts payable
0.48
1.6
1.57
1.03
0.48
1.04
0.28
Accrued liabilities
0.22
0.3
0.82
2.44
0.74
0.36
1.68
Deferred revenue
0.47
0.49
0.11
0
0.24
0.01
0
Short-term debt
0
20
19.5
Total current liabilities
3.52
5.82
10.1
22.4
12.7
32.6
71.1
Long-term debt
4.9
0.56
0
Lease liabilities
0.34
0.22
0.7
0
1.73
1.15
0.36
Other non-current liabilities
-0.68
0.68
Total liabilities
6.18
6.04
19.7
36
17
33.7
234
Total debt
27.7
19.5
Paid-in capital
7.31
25.4
35
0
0
151
253
Retained earnings
-7.1
-4.17
-6.27
-23.2
-46.9
-60.5
-307
Treasury stock
0
Shareholders' equity
2.18
21.2
28.8
27.8
6.52
90.1
-53.8
Minority interests
1.95
0
0.05
-0.51
Total equity
0.23
21.2
28.8
27.8
6.52
90.1
-53.8
Total liabilities and equity
6.4
27.3
48.5
63.8
23.5
124
180
Shares outstanding
0.23
0.23
0.85
1.05
1.05
38.3
78.7
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-5.38
0.62
-2.1
-16.9
-23.7
-13.7
-246
Depreciation and amortization
0.61
1.03
2.73
3.48
3.68
0.76
0.46
Stock-based compensation
0.37
0.61
3.33
3.66
1.17
2.11
21.9
Deferred income tax
1.28
0.57
2
5.6
5.95
-0.01
-0.01
Change in receivables
-0.1
1.14
-0.28
-0.36
0.68
-0.48
0.06
Change in inventory
-0.31
0.85
2.8
-1.37
2.65
-0.47
0.89
Change in payables
0.28
1.97
-0.43
0.39
-0.94
2.87
3.95
Cash from operations
-4.16
2.94
-0.18
0.2
-0.1
-8.42
-21
Capital expenditures
-1.93
-1.42
-5.45
-0.94
-0.93
-0.39
-0.04
Acquisitions
2.57
0.5
-0.54
0
Cash from investing
-1.46
-1.28
-10.9
-2.57
-3.38
-99.3
-30.6
Debt issued
2.65
Stock issued
0.42
11
0
0
92.6
75.2
Share buybacks
0
-2.77
Cash from financing
2.82
12
3.7
-0.29
-0.35
110
54.4
Net change in cash
-2.81
13.6
-6.49
-1.41
-4.42
2.31
2.8
Free cash flow
-6.09
1.52
-5.63
-0.73
-1.03
-8.81
-21
Interest paid
0
0
0.06
2.28
0.84
0.81
8.37
Income taxes paid
0
0
0.66
0
0
0
0.01
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $1.23 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
89.5%
Gross profit / revenue.
Operating margin
-963.5%
Operating income / revenue.
EBITDA margin
-961.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-984.3%
Pre-tax income / revenue.
Net margin
-984.3%
Net income / revenue.
FCF margin
-84.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-83.8%
Cash from operations / revenue.
Return on assets (ROA)
-161.9%
Net income / average total assets.
Return on invested capital (ROIC)
-809.1%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
87.6%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.2%
Capital expenditures / revenue.
D&A / revenue
1.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
58.1%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-11.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
0.7%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
105.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
2.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
13.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-159.7%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
45.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
41.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
45.9%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
702.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
314.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
211.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.64x
Current assets / current liabilities.
Quick ratio
0.08x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.08x
(Cash + short-term investments) / current liabilities.
Debt / assets
10.8%
Total debt / total assets.
Liabilities / assets
129.9%
Total liabilities / total assets.
Net debt
$13.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$3.87
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$3.87
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.39
Revenue / diluted weighted shares.
FCF per share
-$0.33
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.33
Cash from operations / diluted weighted shares.
Book value per share
-$0.68
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
3.61x
Market cap / revenue.
EV/Sales
4.16x
Enterprise value / revenue.
FCF yield
-23.2%
Free cash flow / market cap.
Earnings yield
-272.4%
Net income / market cap (the inverse of P/E).
Shareholder yield
3.1%
(Dividends paid + share buybacks) / market cap.
What was UPEXI, INC.'s revenue in fiscal 2026?
UPEXI, INC. reported revenue of $25.0M for fiscal 2026, 58.1% higher than the year before.
Was UPEXI, INC. profitable in fiscal 2026?
No. It reported a net loss of $246.1M.
How much free cash flow did UPEXI, INC. generate in fiscal 2026?
Cash from operations of $21.0M minus capital expenditures of $44.0K left free cash flow of -$21.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.